<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03606707</url>
  </required_header>
  <id_info>
    <org_study_id>Atlantoaxial injection in RA</org_study_id>
    <nct_id>NCT03606707</nct_id>
  </id_info>
  <brief_title>Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients</brief_title>
  <official_title>Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of intra-articular steroid injection for inflamed atlantoaxial joint in patients
      with rheumatoid arthritis Inclusion criteria Patients with rheumatoid arthritis with MRI
      findings of atlantoaxial joint inflammation and failure of resolution after 2 weeks systemic
      steroid administration Exclusion criteria Coagulopathy, allergy to contrast material,
      pregnancy Interventional group (AS) group, received intra-articular steroid injection for
      atlantoaxial joint. , in addition to methotrexate and chloroquine 400 mg per day.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Efficacy of intra-articular steroid injection for inflamed atlantoaxial joint on sleep
      quality and head and neck pain in patients with rheumatoid arthritis Inclusion criteria
      Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint inflammation and
      failure of resolution after 2 weeks systemic steroid administration Interventional group (AS)
      group, received intra-articular steroid injection for atlantoaxial joint. , in addition to
      methotrexate and chloroquine 400 mg per day.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">July 15, 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>neck pain</measure>
    <time_frame>3 months</time_frame>
    <description>Visual analog scale 0-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>neck disability</measure>
    <time_frame>3 months</time_frame>
    <description>Oswestry Neck Pain Questionnaire 0-50</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sleep quality</measure>
    <time_frame>3 months</time_frame>
    <description>Pittsburgh sleep quality index</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain, Head</condition>
  <condition>Sleep Disturbance</condition>
  <arm_group>
    <arm_group_label>corticosteroid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>steroid group, received intra-articular steroid injection for atlantoaxial joint. , in addition to methotrexate and chloroquine 400 mg per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oral steroid</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>systemic group, received systemic steroid 20 mg/d , in addition to methotrexate and chloroquine 400 mg per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroids</intervention_name>
    <description>intra-articular steroid injection for atlantoaxial joint</description>
    <arm_group_label>corticosteroid</arm_group_label>
    <other_name>cortecosteroid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint
             inflammation and failure of resolution after 2 weeks systemic steroid administration

        Exclusion Criteria:

          -  Coagulopathy, allergy to contrast material, pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manal Hassanien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manal Hassanien, MD</last_name>
    <phone>01062679200</phone>
    <email>manal_hassanien@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abdelraheem Elawamy, MD</last_name>
    <phone>01000032655</phone>
    <email>arawamyyy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Manal Hassanien</name>
      <address>
        <city>Assiut</city>
        <state>Assuit</state>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manal Hassanien, MD</last_name>
      <phone>01062679200</phone>
      <email>manal_hassanien@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Abdelraheem Elawamy, MD</last_name>
      <phone>01000032655</phone>
      <email>arawamyyy@yahoo.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Assiut governorate</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>manal hassanien, MD</last_name>
      <phone>01062679200</phone>
      <email>&lt;manal_hassanien@yahoo.com&gt;</email>
    </contact>
    <contact_backup>
      <last_name>MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <last_update_submitted>July 23, 2018</last_update_submitted>
  <last_update_submitted_qc>July 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Manal Hassanien</investigator_full_name>
    <investigator_title>principle investigaror</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Neck Pain</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Efficacy of intra-articular steroid injection for inflamed atlantoaxial joint in patients with rheumatoid arthritis Inclusion criteria Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint inflammation and failure of resolution after 2 weeks systemic steroid administration Exclusion criteria Coagulopathy, allergy to contrast material, pregnancy Interventional group (AS) group, received intra-articular steroid injection for atlantoaxial joint. , in addition to methotrexate and chloroquine 400 mg per day.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>3 months</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

